Astellas To Pay Up To $1.4B For German Cancer Drug Maker
Latham & Watkins LLP guided Japanese drugmaker Astellas Pharma Inc. through its agreement on Friday to buy venture capital-backed German cancer drug developer Ganymed Pharmaceuticals AG in a cash deal that...To view the full article, register now.
Already a subscriber? Click here to view full article